TF and Alzheimer disease: Since lipid NPs have been functionalized with peptides such as transferrin to target the BBB [111], designing lipid NPs carrying DNA plasmids encoding healthy variants of genes related to transcytosis functionalized with peptides to target BECs is a promising therapeutic strategy for treating AD.